Effect on Osteoclast Differentiation and ER Stress Downregulation by Amygdalin and RANKL Binding Interaction

Effect on Osteoclast Differentiation and ER Stress Downregulation by Amygdalin and RANKL Binding Interaction

Bone diseases such as osteoporosis are the result of osteoclast over-activation. There are many therapeutic agents from natural compounds inhibiting the formation of osteoclast that have been reported and are continuously being interested. Amygdalin (AD) is isolated from seeds of <i>Prunus arm...

Full description

Bibliographic Details
Main Authors:	Nguyen Minh Trang, Eun-Nam Kim, Hyun-Su Lee, Gil-Saeng Jeong
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Biomolecules
Subjects:	amygdalin RANKL osteoclast ROS ER stress molecular docking
Online Access:	https://www.mdpi.com/2218-273X/12/2/256

Similar Items

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
by: Mithun Ghosh, et al.
Published: (2018-03-01)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
by: Eun-Nam Kim, et al.
Published: (2020-08-01)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
by: Gang Wang, et al.
Published: (2022-01-01)

Inhibitory Effects of Protopanaxadiol-Producing Transgenic Rice Seed Extracts on RANKL-Induced Osteoclast Differentiation
by: Yongjin Lee, et al.
Published: (2022-11-01)

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling
by: Yoon-Hee Cheon, et al.
Published: (2020-09-01)

Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption
by: HanGyeol Lee, et al.
Published: (2023-09-01)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01)

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.
by: Hiyoung Kim, et al.
Published: (2014-04-01)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
by: Ineke D.C. Jansen, et al.
Published: (2020-08-01)

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor
by: Emma Persson, et al.
Published: (2019-05-01)

ERK Inhibition Increases RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells by Stimulating AMPK Activation and RANK Expression and Inhibiting Anti-Osteoclastogenic Factor Expression
by: Eun-Bi Choi, et al.
Published: (2022-11-01)

Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
by: Xuan Liu, et al.
Published: (2022-03-01)

Raman Spectroscopic Investigation of Osteoclastic Activity under the Influence of Bisphosphonate
by: Elia Marin, et al.
Published: (2022-04-01)

Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway
by: Dianshan Ke, et al.
Published: (2024-02-01)

Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways
by: Lei Jiang, et al.
Published: (2017-10-01)

Phytol Suppresses Osteoclast Differentiation and Oxidative Stress through Nrf2/HO-1 Regulation in RANKL-Induced RAW264.7 Cells
by: Eun-Nam Kim, et al.
Published: (2022-11-01)

Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast Differentiation
by: Youn-Hwan Hwang, et al.
Published: (2013-06-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Histological analysis of femoral bones in rabbits administered by amygdalin
by: Veronika Kováčová, et al.
Published: (2016-07-01)

The Pharmacological Activities and Toxicological Effects of Amygdalin: A Review
by: Fatemeh Shaki, et al.
Published: (2022-12-01)

Madecassic acid suppresses osteoclast differentiation and bone resorption by inhibiting RANKL‐induced NF‐κB, JNK and NFAT signaling pathways
by: Peiru Su, et al.
Published: (2023-12-01)

Water Extract of Acer tegmentosum Reduces Bone Destruction by Inhibiting Osteoclast Differentiation and Function
by: Hyunil Ha, et al.
Published: (2014-04-01)

Protection against Osteoporosis by Fermented Mulberry Vinegar Supplementation via Inhibiting Osteoclastic Activity in Ovariectomized Rats and Osteoclastic Cells
by: Eun Jung Yim, et al.
Published: (2022-05-01)

The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
by: Yan Zhang, et al.
Published: (2022-12-01)

Colony-Level Effects of Amygdalin on Honeybees and Their Microbes
by: James P. Tauber, et al.
Published: (2020-11-01)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
by: P. Narducci, et al.
Published: (2010-03-01)

Biological Evaluation and Transcriptomic Analysis of Corylin as an Inhibitor of Osteoclast Differentiation
by: Anna Xiao-Dan Yu, et al.
Published: (2021-03-01)

Nrf2 is required for suppressing osteoclast RANKL-induced differentiation in RAW 264.7 cells via inactivating cannabinoid receptor type 2 with AM630
by: Wan Li, et al.
Published: (2020-06-01)

Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
by: Chun-Lin Liu, et al.
Published: (2023-10-01)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01)

Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
by: Tarek El-Sewedy, et al.
Published: (2023-09-01)

Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
by: Jianbo He, et al.
Published: (2023-12-01)

Inflammation, It’s Regulation and Antiphlogistic Effect of the Cyanogenic Glycoside Amygdalin
by: Daniela Figurová, et al.
Published: (2021-10-01)

Impact of intestinal microbiota on metabolic toxicity and potential detoxification of amygdalin
by: Qiuyu Wen, et al.
Published: (2022-11-01)

Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways
by: XiaoLi Jin, et al.
Published: (2022-01-01)

Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
by: Sang-Yong Han, et al.
Published: (2021-12-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Amygdalin as a chemoprotective agent in co-treatment with cisplatin
by: Panayiota Christodoulou, et al.
Published: (2022-09-01)

In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin as a Cancer Therapy
by: Fatma I. Abo El-Ela, et al.
Published: (2022-10-01)